dockets: DEA-2023-0029

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
DEA-2023-0029 DEA Telemedicine Prescribing of Controlled Substances (DEA407) Rulemaking 2026-01-12T22:00:12Z 0b00006485728671 1117-AB40 The Drug Enforcement Administration proposes a Special Registration for Telemedicine framework, authorizing certain DEA-registered practitioners to engage in the practice of telemedicine under the Ryan Haight Act. The three types of Special Registration, include: (1) the Telemedicine Prescribing Registration, authorizing qualified clinician practitioners to prescribe Schedule III-V controlled substances; (2) the Advanced Telemedicine Prescribing Registration, authorizing qualified specialized clinician practitioners to prescribe Schedule II-V controlled substances; and (3) the Telemedicine Platform Registration authorizing qualified covered online telemedicine platforms, in their capacity as platform practitioners, to dispense Schedule II-V controlled substances. The rule also provides heightened prescription, recordkeeping, and reporting requirements.               {"displayProperties": [], "keywords": null, "modifyDate": "2026-01-12T22:00:12Z", "dkAbstract": "The Drug Enforcement Administration proposes a Special Registration for Telemedicine framework, authorizing certain DEA-registered practitioners to engage in the practice of telemedicine under the Ryan Haight Act. The three types of Special Registration, include: (1) the Telemedicine Prescribing Registration, authorizing qualified clinician practitioners to prescribe Schedule III-V controlled substances; (2) the Advanced Telemedicine Prescribing Registration, authorizing qualified specialized clinician practitioners to prescribe Schedule II-V controlled substances; and (3) the Telemedicine Platform Registration authorizing qualified covered online telemedicine platforms, in their capacity as platform practitioners, to dispense Schedule II-V controlled substances. The rule also provides heightened prescription, recordkeeping, and reporting requirements.", "agencyId": "DEA", "program": null, "shortTitle": null, "subType2": null, "title": "Telemedicine Prescribing of Controlled Substances (DEA407)", "generic": null, "field1": null, "docketType": "Rulemaking", "petitionNbr": null, "rin": "1117-AB40", "organization": null, "legacyId": null, "subType": null, "category": null, "field2": null, "effectiveDate": null, "objectId": "0b00006485728671"} single_get

Links from other tables